Showing results (1431-1440 of 1,686) with videos related to

Sort By:
Pageof 169
AIDS (London, England)|May 11, 2018
Perinatally acquired HIV infection accelerates epigenetic aging in South African adolescentsSteve Horvath, Dan J Stein, Nicole Phillips, et al.
Journal of Occupational and Environmental Medicine|April 12, 2018
Patient Satisfaction Measurement in Occupational and Environmental Medicine PracticeDavid L Drury, Philip Adamo, Marianne Cloeren, et al.
Hepatology (Baltimore, Md.)|December 1, 1989
A multicenter, randomized, double-blind trial of somatostatin in the management of acute hemorrhage from esophageal varicesJ E Valenzuela, T Schubert, M R Fogel, et al.
Journal of the American College of Cardiology|July 1, 1990
Ethics in cardiovascular medicine. Task Force IV: Scientific responsibility and integrity in medical researchP L Frommer, J Ross, J A Benson, et al.
The Journal of Allergy and Clinical Immunology|March 16, 2019
Apolipoprotein E is a concentration-dependent pulmonary danger signal that activates the NLRP3 inflammasome and IL-1β secretion by bronchoalveolar fluid macrophages from asthmatic subjectsElizabeth M Gordon, Xianglan Yao, Haitao Xu, et al.
Geroscience|April 12, 2022
HIV, pathology and epigenetic age acceleration in different human tissuesSteve Horvath, David T S Lin, Michael S Kobor, et al.
American Journal of Veterinary Research|January 23, 2022
Circulating neutrophil activation in dogs with naturally occurring spinal cord injury secondary to intervertebral disk herniationRae L Van Sandt, C Jane Welsh, Nick D Jeffery, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 16, 2021
Cell contact guidance via sensing anisotropy of network mechanical resistanceGreeshma Thrivikraman, Alicja Jagiełło, Victor K Lai, et al.
Archives of Surgery (Chicago, Ill. : 1960)|April 1, 1989
Hemodynamic effects on endothelial cell monolayer detachment from vascular prosthesesH P Greisler, E D Endean, J J Klosak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2003
A phase I-II study of rituximab, ifosfamide, mitoxantrone and etoposide (R-IME) for B cell non-Hodgkin's lymphoma prior to and after high-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT)R M Joyce, M Regan, J Ottaway, et al.
Pageof 169